Intimate exosomes is a patient-facing term for exosome-based regenerative support discussed in women’s intimate health. Exosomes are small extracellular vesicles involved in cell communication. In clinic, the term must be used carefully because products, sources, evidence and delivery routes vary.

You may see the terms vaginal exosomes, vaginal exosome treatment or exosome vaginal rejuvenation online. They are used inconsistently. At WHC, we prefer clearer wording and explain that any treatment discussion must be linked to product source, route, regulation and suitability.

No injectable exosome product currently holds UK marketing authorisation for aesthetic practice. WHC does not promote vaginal exosome injections. Any exosome-based support must be discussed in a regulatory-aware way.

Human-derived exosome products, including donor, stem-cell, umbilical-cord or placental-derived products, raise significant UK regulatory and safety concerns in cosmetic and aesthetic use. WHC would only discuss a product where source, status and intended use had been verified.

Exosomes are involved in cell-to-cell communication and can carry signalling molecules. Research into exosomes in regenerative medicine explores tissue repair, wound healing, inflammation modulation and skin quality. Direct intimate-health evidence remains emerging.

Some women with vaginal dryness ask about exosome-based support, but dryness can have several causes, including menopause-related changes, irritation, skin conditions, medication factors or infection. Exosomes should not be presented as a cure for dryness.

Many women enquiring about intimate exosomes are experiencing menopause-related vaginal or urinary changes. A consultation should also discuss established menopause and GSM options, rather than treating exosomes as the only route.

Some women enquire after childbirth, but timing, breastfeeding, pelvic floor symptoms and recovery all matter. A consultation helps decide whether exosome-based support, pelvic floor support, vaginal rejuvenation or another pathway is more appropriate.

Comfort depends on the final protocol. Topical application, applicator-based use, laser-assisted treatment and microneedling-assisted treatment are different experiences. We explain what is proposed before consent.

Recovery depends on the actual procedure used. If treatment is procedure-assisted, temporary redness, tenderness, irritation or sensitivity may be possible. You will receive clear aftercare guidance.

Results vary. Some product-led protocols describe gradual changes over weeks, but WHC should only discuss timing after confirming the product, protocol and suitability. Some women may not notice meaningful improvement.

Duration varies between individuals and depends on product, protocol, tissue quality, hormonal status and the concern being discussed. Maintenance or repeat treatment should not be assumed before assessment.

Possible effects depend on the route and any accompanying procedure. These may include temporary irritation, sensitivity, redness, tenderness, infection risk if the skin barrier is disrupted, or disappointing results. Relevant risks are discussed before treatment.

A doctor-led face-to-face consultation is advised and is currently £150. Treatment pricing should be confirmed after assessment and by checking the latest pricing page, because the correct pathway may differ between patients.

No. Vaginal rejuvenation is a broader umbrella term. Exosome-based support is one possible discussion within that wider pathway, alongside other approaches that may be more suitable for some women.

It may not be appropriate during pregnancy, with active infection, unexplained bleeding, significant pelvic pain, suspicious skin changes, certain immune or healing issues, unclear product status, or unrealistic expectations. Suitability is confirmed only after consultation and assessment.

Polynucleotides are purified DNA fragments used in injectable regenerative aesthetics. Exosome-based products are separate and are usually discussed in relation to signalling and cellular communication. They are not interchangeable.

O-Shot / PRP uses platelet-rich plasma prepared from your own blood. Exosome products are not PRP and may come from different product sources depending on the manufacturer.

Vaginal laser is an energy-based treatment used within broader vaginal rejuvenation pathways. Exosome-based support is a different category and should be discussed separately, not treated as the same treatment under another name.